Joseph G. Darling
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joseph G. Darling
Joseph G. Darling was last confirmed as CEO at Anika Therapeutics, Inc. (ANIK) in a filing dated April 29, 2020. The proxy statement of Anika Therapeutics, Inc. reports total compensation of $288,753 for Joseph G. Darling in fiscal 2020, including a base salary of $80,752. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2020-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Anika Therapeutics, Inc. (ANIK) | President and Chief Executive Officer | $80,752 | $288,753 |
| 2019 | Anika Therapeutics, Inc. (ANIK) | President and Chief Executive Officer | $599,500 | $5,590,182 |
| 2018 | Anika Therapeutics, Inc. (ANIK) | President and Chief Executive Officer | $523,462 | $2,170,187 |
| 2017 | Anika Therapeutics, Inc. (ANIK) | President and Chief Executive Officer | $181,987 | $1,782,212 |
Recent activity
No call appearances or filed executive changes recorded yet.